Attendo runs elder care, residential care homes and disability and psychiatric care services in the Nordics, Germany and the UK, with care delivered under long-term municipal and public contracts. The moat is the regulated, contract-based nature of that work: public payers are sticky, and operators with scale and quality records win repeat tenders. Revenue growth has slowed to 1.3%, which is the central issue, and the forward P/E of 26.9 against a trailing 17.3 implies the market expects earnings to fall, so a recovery in volumes or margins is what would justify a closer look. Operating margin of 9.4% against a 36.9% gross margin shows how much of the gross profit is absorbed by staff and overhead, so every point of margin recovered matters more than top-line growth at this stage. ROE of 18.7% is solid, but the thesis needs evidence that occupancy and wage cost trends are improving before the stock merits deeper work.
Plain-English pros, cons, and what to watch. Pro feature.
See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.
The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
Trades are only made public after a delay. We show the delay so you know how old the news is.
Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.
| Date | Type | New | Previous | Price |
|---|---|---|---|---|
| 23 Oct 2026, 01:53 CEST | ACCE price target | kr 126 | first publication | kr 115 |
| 22 Oct 2026, 13:04 CEST | Fair value | kr 135 | first publication | kr 117 |
| 22 Oct 2026, 13:04 CEST | Rating | Fairly valued | first publication | kr 117 |
Answered from Attendo AB (publ) fundamentals + recent valuations. Every number shows its source and date.
| Company | Price | Fair value | vs fair value | P/E | ROE | Quality | Score |
|---|---|---|---|---|---|---|---|
| ATT.ST Attendo AB (publ) | kr 114.80 | kr 135 | 15% below | 16.9x | 18.7% | 52 | 63 |
| SIA.TO Sienna Senior Living Inc. | C$20.53 | C$11 | 86% above | 38.7x | 6.7% | 42 | 50 |
| ARDT Ardent Health Inc. Common Stock | $12.27 | $16 | 25% below | 22.7x | 10.0% | 47 | 53 |
| AMN AMN Healthcare Services Inc | $48.01 | $71 | 33% below | 17.9x | 15.6% | 52 | 73 |
| ASTH Astrana Health Inc. Common Stock | $37.45 | - | - | 44.7x | 6.9% | 35 | 72 |
| AMBEA.ST Ambea AB (publ) | kr 181.80 | kr 217 | 16% below | 19.1x | 15.5% | 47 | 68 |
| SGRY Surgery Partners Inc. Common Stock | $15.75 | $10 | 52% above | - | 2.3% | 33 | 43 |
Where ATT.ST ranks against its sector peers on each metric.